-
Mashup Score: 0Call Me Back - with Dan Senor on Apple Podcasts - 11 day(s) ago
News · 2024
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Chromoplexy is detectable using targeted NGS in a substantial portion of EWSR1-rearranged round cell sarcomas as an early and persistent clonal event, expanding the genomic complexity of fusion-associated sarcomas.
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML - 21 day(s) ago
PURPOSE Azacitidine plus venetoclax is a standard of care for patients with newly diagnosed AML who are unfit for intensive chemotherapy. However, FLT3 mutations are a common mechanism of resistance to this regimen. The addition of gilteritinib, an oral FLT3 inhibitor, to azacitidine and venetoclax may improve outcomes in patients with FLT3-mutated AML. METHODS This phase I/II study evaluated azacitidine, venetoclax, and gilteritinib in two cohorts: patients with (1) newly diagnosed FLT3-mutated AML who were unfit for intensive chemotherapy or (2) relapsed/refractory FLT3-mutated AML (ClinicalTrials.gov identifier: NCT04140487). The primary end points were the maximum tolerated dose of gilteritinib (phase I) and the combined complete remission (CR)/CR with incomplete hematologic recovery (CRi) rate (phase II). RESULTS Fifty-two patients were enrolled (frontline [n = 30]; relapsed/refractory [n = 22]). The recommended phase II dose was gilteritinib 80 mg once daily in combination with a
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q) - 1 month(s) ago
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0What Conditions Account for US Health Spending? - 2 month(s) ago
The Bureau of Economic Analysis releases interesting data on health spending by condition.
Source: healthy-skeptic.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 43A spatiotemporal proteomic map of human adipogenesis - 2 month(s) ago
Nature Metabolism – Klingelhuber, Frendo-Cumbo et al. develop a proteomic atlas elucidating the intracellular spatiotemporal changes in protein levels and localizations during human adipogenesis.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0R.I.P. Louis Gossett Jr.: First Black actor to win Oscar for Best... - 2 month(s) ago
The award was for his role in the 1982 romantic drama An Officer and a Gentleman.
Source: decider.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15 Things To Know About Colon Cancer Prevention and Screening - 2 month(s) ago
Colorectal cancer is the third most common cancer in the United States, and more than 150,000 people will be diagnosed with colorectal cancer this year. For
Source: medicine.yale.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Joe Lieberman, 2000 vice presidential nominee, dies at 82 - 2 month(s) ago
He was the first Jewish American to be nominated on a major party’s ticket.
Source: www.politico.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0stats - 2 month(s) ago
National Center for Health Statistics
Source: www.cdc.govCategories: General Medicine News, Hematologists1Tweet
listen to sheryl sandberg https://t.co/8yYxXLJK2I